Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price and are well-covered. Analyst forecasts suggest top Dow Dogs could de
Explore the exciting world of UnitedHealth (UNH 1.53%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market tre
Dividend stocks that offer high yields can be gold mines for your portfolio as they can generate loads of recurring income for you for years. Whether you want to use the money to reinvest in those sto
Barclays analyst Andrew Mok raised the firm's price target on UnitedHealth to $362 from $337 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care a
Barclays lowered the firm's price target on Molina Healthcare to $185 from $186 and keeps an Equal Weight rating on the shares. The firm adjusted estimates and targets in the managed care and healthca
Barclays raised the firm's price target on Elevance Health to $373 from $327 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare fa
Barclays analyst Andrew Mok raised the firm's price target on CVS Health to $87 from $80 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and h
Barclays raised the firm's price target on Cigna to $383 from $354 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare facility gro
Barclays analyst Andrew Mok lowered the firm's price target on Centene to $33 from $45 and keeps an Equal Weight rating on the shares. The firm adjusted estimates and targets in the managed care and h
If you buy a stock that goes up 20% in a year, I'd say you made a good investment. After all, the S&P 500 (^GSPC 0.51%) returns somewhere around 10% annually on average.
UnitedHealth's stock is deeply undervalued after a tough 2025, but market pessimism exceeds the company's actual fundamentals. A major premium repricing cycle in 2026 should restore margins and profit
I'm a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he's made some incredible (albeit high-stakes) calls, even in the years that followed his bi

3 Best Stocks to Buy in September

06:30am, Wednesday, 03'rd Sep 2025
September has a dark reputation -- it's historically the weakest month for stocks. Since 1928, the S&P 500 has dropped an average of 1.2% in September, with declines in 56% of those months.
With its gain of 3.2%, the Dow Jones Industrial Average (^DJI -1.16%) outperformed most other major market indexes in August. Only a small handful of the Dow's constituents, however, did the bulk of t
When all was said and done, last month ended up being a decent one for the broad market. The S&P 500 (^GSPC -1.50%) ended August 1.9% above where it started.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE